MyFinsight
Home
Blog
About
Zimmer_Biomet_logo-svg
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Zimmer_Biomet_logo-svg
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$393,600K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net earnings
Accounts payable and accrued lia...
Net proceeds from revolving faci...
Others
Negative Cash Flow Breakdown
Repurchase of common stock
Additions to instruments
Income taxes
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net earnings
199,600
238,300
137,900
567,200
Depreciation and amortization
270,800
270,000
284,000
283,600
Share-based compensation
24,600
24,200
24,100
25,300
Deferred income tax benefit
-
-
-87,200
-
Income taxes
-72,700
-7,400
8,100
-42,700
Receivables
38,500
-14,500
111,700
-3,000
Inventories
30,500
20,900
-184,400
46,000
Accounts payable and accrued liabilities
92,000
-183,000
112,900
-51,500
Other assets and liabilities
-2,600
-23,500
35,100
-15,800
Net cash provided by operating activities
447,800
359,400
517,400
418,700
Additions to instruments
85,400
77,200
74,300
86,000
Additions to other property, plant and equipment
54,200
36,300
74,800
55,000
Net investment hedge settlements
-11,100
300
-4,900
8,800
Business combination investments, net of acquired cash
-
-
166,900
0
Acquisition of intangible assets
62,200
39,000
10,000
10,000
Other investing activities
100
6,200
800
3,500
Net cash used in investing activities
-190,800
-159,000
-322,000
-163,300
Proceeds from senior notes
-
-
0
744,000
Redemption of senior notes
-
-
600,000
0
Net proceeds from revolving facilities
30,000
-
-
-
Dividends paid to stockholders
46,500
46,900
47,500
47,500
Proceeds from employee stock compensation plans
100
12,300
1,700
20,900
Business combination contingent consideration payments
200
69,000
0
7,600
Debt issuance costs
1,300
-
0
5,400
Repurchase of common stock
250,700
250,100
250,000
0
Other financing activities
-2,300
-15,600
-1,100
-500
Net cash (used in) provided by financing activities
-271,100
-369,200
-897,000
483,800
Effect of exchange rates on cash and cash equivalents
0
1,100
800
-3,400
Change in cash and cash equivalents
-14,200
-167,700
-700,800
735,800
Cash and cash equivalents, beginning of year
424,200
591,900
1,384,500
1,384,500
Cash and cash equivalents, end of period
410,000
424,200
591,900
1,292,700
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Depreciation and
amortization
$270,800K
(-0.37%↓ Y/Y)
Net earnings
$199,600K
(30.12%↑ Y/Y)
Accounts payable and
accrued liabilities
$92,000K
(19.79%↑ Y/Y)
Share-based compensation
$24,600K
(16.04%↑ Y/Y)
Other assets and
liabilities
-$2,600K
(69.05%↑ Y/Y)
Net cash provided by
operating activities
$447,800K
(18.40%↑ Y/Y)
Canceled cashflow
$141,700K
Change in cash and cash
equivalents
-$14,200K
(98.28%↑ Y/Y)
Canceled cashflow
$447,800K
Net proceeds from
revolving facilities
$30,000K
(-86.36%↓ Y/Y)
Proceeds from employee
stock compensation...
$100K
(-75.00%↓ Y/Y)
Net investment
hedge settlements
-$11,100K
(-344.00%↓ Y/Y)
Income taxes
-$72,700K
(37.54%↑ Y/Y)
Receivables
$38,500K
(19350.00%↑ Y/Y)
Inventories
$30,500K
(-18.01%↓ Y/Y)
Net cash (used in)
provided by financing...
-$271,100K
(-265.51%↓ Y/Y)
Canceled cashflow
$30,100K
Net cash used in
investing activities
-$190,800K
(86.22%↑ Y/Y)
Canceled cashflow
$11,100K
Repurchase of common stock
$250,700K
(3381.94%↑ Y/Y)
Dividends paid to
stockholders
$46,500K
(-2.11%↓ Y/Y)
Other financing
activities
-$2,300K
(-155.56%↓ Y/Y)
Debt issuance costs
$1,300K
(8.33%↑ Y/Y)
Business combination
contingent consideration...
$200K
Additions to instruments
$85,400K
(6.09%↑ Y/Y)
Acquisition of intangible
assets
$62,200K
(107.33%↑ Y/Y)
Additions to other
property, plant and...
$54,200K
(8.18%↑ Y/Y)
Other investing
activities
$100K
Buy us a coffee